Submit an abstract for the Spotlight on Immuno-Oncology conference by June 2, 11:59 p.m. PT
Advocate on behalf of members to lawmakers and policymakers to support the success of and patient access to gene and cell therapy.
ASGCT will represent scientists, physicians, patient advocates, and other stakeholders to lawmakers and policymakers.
The Society will advocate to maximize access, promote a regulatory environment that supports clinical translation, and ensure robust research funding to propel scientific advancement of gene and cell therapy. ASGCT will mediate internal and public dialogue on how best to maximize access to gene therapy.
Download the Full 2020 ASGCT Strategic Plan
ASGCT is committed to seizing on the tremendous growth in the science and clinical application of gene and cell therapy, supporting the global impact of our work, and strengthening the Society’s infrastructure.
Educate members and other stakeholders on multiple platforms, empowering communities to advance the science and application of gene and cell therapy.
Foster global outreach by advancing knowledge, education, and awareness of gene and cell therapy around the world.
Sept. 18-19 | Washington, DC
© 2000-2023 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico